Document is current
Any future updates will be listed below
-
Authors
Kong, Isabella Y.
Trezise, Stephanie http://orcid.org/0000-0002-7511-3291
Light, Amanda
Todorovski, Izabela
Arnau, Gisela Mir
Gadipally, Sreeja
Yoannidis, David
Simpson, Kaylene J.
Dong, Xueyi
Whitehead, Lachlan
Tempany, Jessica C.
Farchione, Anthony J.
Sheikh, Amania A.
Groom, Joanna R.
Rogers, Kelly L. http://orcid.org/0000-0002-6755-0221
Herold, Marco J. http://orcid.org/0000-0001-7539-7581
Bryant, Vanessa L.
Ritchie, Matthew E. http://orcid.org/0000-0002-7383-0609
Willis, Simon N.
Johnstone, Ricky W.
Hodgkin, Philip D.
Nutt, Stephen L. http://orcid.org/0000-0002-0020-6637
Vervoort, Stephin J. http://orcid.org/0000-0001-7459-126X
Hawkins, Edwin D. http://orcid.org/0000-0002-3686-8261
- License Information
-
More Information
Article History
Received: 21 December 2021
Revised: 16 June 2022
Accepted: 21 June 2022
First Online: 13 July 2022
Competing interests
: The Johnstone laboratory (SJV and RWJ) has received project support from AstraZeneca, Roche, MecRx, and BMS. RWJ is a paid consultant and shareholder of MecRx.
